Key Metrics
2.7
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
19
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q2
Pharmacology (medical)
SJR
- Q2 Pharmacology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.87
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Blood pressure
- Intellectual disability
- Multiple sclerosis
- Observational study
- Rapid infusion
- Polypharmacy
- Diclofenac
- Epidermal growth factor receptor
- Systematic review
- Antidepressant
- Psoriatic arthritis
- Potentially Inappropriate Medications
- Daratumumab
- Osteomyelitis
- Cohort study
- Adult patients
- Body mass index
- Intensive care unit
- QT interval
- Adjuvant therapy
Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 2190 | USD 2690 | GBP 1890 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 8 |
| Article Processing Charges | EUR 2190 | USD 2690 | GBP 1890 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
Planning to publish in Drugs - Real World Outcomes ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Prevalence and Patterns of Use of Natural Health Products and Medicines in New Zealand: A Pilot Study Using an Online Market Research Panel.
- 19 Mar 25
- Drugs - real world outcomes
-
Full paper
Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World Cohort.
- 14 Mar 25
- Drugs - real world outcomes
-
Full paper
Correction: Clinical Significance of Prior Ramucirumab Use on the Effectiveness of Nivolumab as the Third-Line Regimen in Gastric Cancer: A Multicenter Retrospective Study.
- 11 Mar 25
- Drugs - real world outcomes
-
Full paper
Effectiveness and Safety of Vildagliptin Sustained Release in the Management of Type 2 Diabetes Mellitus: Real-World Evidence in Indian Patients [NOVELTY Study
- 1 Mar 25
- Drugs - real world outcomes
-
Full paper
Patients' Health-Related Quality of Life and Use of Medicinal Cannabis: A Cross-Sectional Survey Study.
- 1 Mar 25
- Drugs - real world outcomes
-
Full paper
Characteristics of Patients with Hereditary Angioedema Who Reduced Lanadelumab Treatment Administration Frequency: A Retrospective Observational Study of US Claims Data.
- 1 Mar 25
- Drugs - real world outcomes
Scite analysis
Powered by scite_
448 articles received 3.3k citations see all
- 218 Supporting
- 2,941 Mentioning
- 46 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 3 Corrections
- 3 Errata
- 0 Expression of Concern
FAQs
How long has Drugs - Real World Outcomes been actively publishing?
Drugs - Real World Outcomes has been in operation since 2014 till date.
What is the publishing frequency of Drugs - Real World Outcomes ?
Drugs - Real World Outcomes published with a Quarterly frequency.
How many articles did Drugs - Real World Outcomes publish last years ?
In 2024, Drugs - Real World Outcomes published 62 articles.
What is the eISSN & pISSN for Drugs - Real World Outcomes ?
For Drugs - Real World Outcomes,eISSN is 2198-9788 and pISSN is2199-1154.
What is Citescore for Drugs - Real World Outcomes ?
Citescore for Drugs - Real World Outcomes is 2.7.
What is H index for Drugs - Real World Outcomes ?
H index for Drugs - Real World Outcomes is 19.
What is SNIP score for Drugs - Real World Outcomes ?
SNIP score for Drugs - Real World Outcomes is 0.87.
What is the SJR for Drugs - Real World Outcomes ?
SJR for Drugs - Real World Outcomes is Q2.
Who is the publisher of Drugs - Real World Outcomes ?
SPRINGERNATURE is the publisher of Drugs - Real World Outcomes.